Patent Application
Provisional
App. No. 62/549,564
· Confirmation No. 8933
Treatment Strategy For Non-Responders To 100MG Subcutaneous Mepolizumab
Provisional Application Expired
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2017-09-05 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2017-08-24 | TR.PROV |
Provisional Cover Sheet (SB16) | 3 | View | |
| 2017-08-24 | DRW |
Drawings-only black and white line drawings | 6 | View | |
| 2017-08-24 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2017-08-24 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2017-08-24 | SPEC |
Specification | 16 | View | |
| 2017-08-24 | CLM |
Claims | 2 | View | |
| 2017-08-24 | ABST |
Abstract | 1 | View |
Inventors
Parameswaran Nair
Dundas, CANADA
Manali Mukherjee
Hamilton, CANADA
Attorneys & Agents of Record
Prosecution
- Customer No.
- 46347
- Docket No.
- 102085.000376/SYD010-US-P
- Confirmation No.
- 8933
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2020-03-10
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 62/549,564
- Filed
- 2017-08-24
External Links